Company intelligence / Profile preview

NEXI Biotech

Ownership: Private
Development stage: Preclinical

Overview

NEXI Biotech serves as a commercial and technical consultancy focused on advancing the adoption of complex, human-relevant in vitro models—such as microphysiological systems—for use in preclinical drug development. Their work has been recognized through successful translation of such models into clinical trial settings and citation within the FDA Modernization Act 2.0. They do not develop therapeutics themselves but enable technology providers and pharma/biopharma companies to improve translational relevance of their preclinical research.

Modalities: In vitro modelsMicrophysiological systems
Industry: Drug Discovery Services

Partnerships

Network-based alliances

Beyond the preview

Go deeper on NEXI Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEXI Biotech.

Explore the full profile